Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus

NCT05501002 is registered in ClinicalTrials.gov with CereVasc Inc as lead sponsor.

NCT NCT05501002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05501002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
US Pilot Study to Evaluate the Safety and Effectiveness of the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus
Lead sponsor
CereVasc Inc
Phase
Not applicable
Overall status
Terminated
Start date
September 15, 2022
Completion date
September 15, 2023
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hydrocephalus, hydrocephalus, communicating